Clinical Trials Logo

Clinical Trial Summary

This project explores Ginkgo biloba ester dispersible tablets influence on cognitive function in patients with mild-to-moderate elderly, to observe the effects of different intervention time on cognitive function, for alzheimer's patients in drug rehabilitation treatment provides an effective solution.


Clinical Trial Description

The assessment of cognitive scales included Minimum Mental State Examination(MMSE), Alzheimer's Disease Assessment Scale-cognition(ADAS-cog), Neuropsychiatric inventory(NPI), quality of Life of Life in Alzheimer's disease(Qol-ADL), activities of Daily living(ADL), Geriatric Depression scale(GDS).Biochemical test included cholesterol, triglycerides, and low density lipoprotein. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03090516
Study type Interventional
Source The First Affiliated Hospital with Nanjing Medical University
Contact Ting Wu
Phone 18851122018
Email wuting80000@126.com
Status Recruiting
Phase Phase 2/Phase 3
Start date August 10, 2016
Completion date March 10, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT05655195 - Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy N/A